The recognition of unique cancer mutations could be responsible for complete cancer regressions in metastatic melanoma patients treated with immunotherapy, a new approach has found. This new approach may help develop more effective cancer immunotherapies, according to a study published in iClinical Cancer Research/i, a journal of the American Association for Cancer Research. "This study provides the technical solution to identify mutated tumor targets that can ...Tuesday, 1 July 2014
Cancer Mutations Identified As Targets Of Melanoma Immunotherapy
The recognition of unique cancer mutations could be responsible for complete cancer regressions in metastatic melanoma patients treated with immunotherapy, a new approach has found. This new approach may help develop more effective cancer immunotherapies, according to a study published in iClinical Cancer Research/i, a journal of the American Association for Cancer Research. "This study provides the technical solution to identify mutated tumor targets that can ...
No comments:
Post a Comment